Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Thermal Compatibility of New ACEI Derivatives with Popular Excipients Used to Produce Solid Pharmaceutical Formulations

M. Broncel, A. Juszczak, W. Szczolko, D. Silvestri, A. Białek-Dratwa, S. Wacławek, O. Kowalski, P. Ramos

. 2024 ; 17 (10) : . [pub] 20241003

Status not-indexed Language English Country Switzerland

Document type Journal Article

Grant support
PCN-2-010/N/2/F, BNW-2-104/K/3/F Mateusz Broncel
PCN-1-021/K/2/F Paweł Ramos

Background/Objectives: Increasing drugs' stability and adequately protecting them against degradation will ensure a decrease in their price and broader availability of pharmaceutical substances. This is of great importance, especially for drugs used to treat the most common diseases in the population, such as hypertension. The study examined two newly synthesized substances from the angiotensin I-converting enzyme inhibitor (ACEI) group as potential drugs. ACEIs are among the leading drugs used in the treatment of hypertension in the world. The chemical modifications of the tested substances applied concerned the places most susceptible to degradation. The presented work analyzed the compatibility of new derivatives with selected excipients used in pharmacy. Methods: Thermogravimetric (TGA) and differential thermal analyses (c-DTA) were used as the main methods. In addition, non-thermal methods such as colorimetry analysis, Fourier-transform infrared (FTIR) and UV spectroscopy were used. Results: Based on the conducted studies, it can be concluded that the incompatibility of IND-1 with glucose anhydrous and lactose monohydrate occurs only when the mixture is stored at higher temperatures. For the remaining IND-1 and IND-2 mixtures with excipients, compatibility was demonstrated. Conclusions: The obtained results confirmed the usefulness of the applied thermal analyses (TGA and c-DTA) for assessing the compatibility of the tested potential drugs with excipients. However, in the case of incompatibility reactions of substances occurring under the influence of elevated temperatures, such as the Maillard reaction, it is necessary to use non-thermal methods to obtain the right result.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002423
003      
CZ-PrNML
005      
20250123101923.0
007      
ta
008      
250117s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph17101323 $2 doi
035    __
$a (PubMed)39458964
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Broncel, Mateusz $u Department of Biophysics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland $u Doctoral School, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland
245    10
$a Thermal Compatibility of New ACEI Derivatives with Popular Excipients Used to Produce Solid Pharmaceutical Formulations / $c M. Broncel, A. Juszczak, W. Szczolko, D. Silvestri, A. Białek-Dratwa, S. Wacławek, O. Kowalski, P. Ramos
520    9_
$a Background/Objectives: Increasing drugs' stability and adequately protecting them against degradation will ensure a decrease in their price and broader availability of pharmaceutical substances. This is of great importance, especially for drugs used to treat the most common diseases in the population, such as hypertension. The study examined two newly synthesized substances from the angiotensin I-converting enzyme inhibitor (ACEI) group as potential drugs. ACEIs are among the leading drugs used in the treatment of hypertension in the world. The chemical modifications of the tested substances applied concerned the places most susceptible to degradation. The presented work analyzed the compatibility of new derivatives with selected excipients used in pharmacy. Methods: Thermogravimetric (TGA) and differential thermal analyses (c-DTA) were used as the main methods. In addition, non-thermal methods such as colorimetry analysis, Fourier-transform infrared (FTIR) and UV spectroscopy were used. Results: Based on the conducted studies, it can be concluded that the incompatibility of IND-1 with glucose anhydrous and lactose monohydrate occurs only when the mixture is stored at higher temperatures. For the remaining IND-1 and IND-2 mixtures with excipients, compatibility was demonstrated. Conclusions: The obtained results confirmed the usefulness of the applied thermal analyses (TGA and c-DTA) for assessing the compatibility of the tested potential drugs with excipients. However, in the case of incompatibility reactions of substances occurring under the influence of elevated temperatures, such as the Maillard reaction, it is necessary to use non-thermal methods to obtain the right result.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Juszczak, Anna $u Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland
700    1_
$a Szczolko, Wojciech $u Chair and Department of Chemical Technology of Drug, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland $1 https://orcid.org/0000000207984626
700    1_
$a Silvestri, Daniele $u Institute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Stdentská 2, 460 01 Liberec, Czech Republic
700    1_
$a Białek-Dratwa, Agnieszka $u Department of Human Nutrition, Department of Dietetics, Faculty of Public Health in Bytom, Medical University of Silesia, Jordana 19, 41-808 Zabrze, Poland $1 https://orcid.org/0000000277986424
700    1_
$a Wacławek, Stanisław $u Institute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Stdentská 2, 460 01 Liberec, Czech Republic $1 https://orcid.org/0000000284308269
700    1_
$a Kowalski, Oskar $u Department of Human Nutrition, Department of Dietetics, Faculty of Public Health in Bytom, Medical University of Silesia, Jordana 19, 41-808 Zabrze, Poland
700    1_
$a Ramos, Paweł $u Department of Biophysics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland $1 https://orcid.org/0000000300306002
773    0_
$w MED00184066 $t Pharmaceuticals $x 1424-8247 $g Roč. 17, č. 10 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39458964 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101917 $b ABA008
999    __
$a ok $b bmc $g 2254569 $s 1238426
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 17 $c 10 $e 20241003 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
GRA    __
$a PCN-2-010/N/2/F, BNW-2-104/K/3/F $p Mateusz Broncel
GRA    __
$a PCN-1-021/K/2/F $p Paweł Ramos
LZP    __
$a Pubmed-20250117

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...